Application 211564
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPAGLIFLOZIN | DAPAGLIFLOZIN | UNKNOWN | UNKNOWN | No | No |
| 002 | DAPAGLIFLOZIN | DAPAGLIFLOZIN | TABLET;ORAL | 10MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapagliflozin | DAPAGLIFLOZIN | Aurobindo Pharma Limited | f56593f7-588e-489d-9fad-b459e90dab18 | 2026-07-17 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| FARXIGA | DAPAGLIFLOZIN | A-S Medication Solutions | 01f90c94-71cb-4a1f-81ff-8004b850529b | 2026-07-10 | Warnings, Adverse reactions | DAPAGLIFLOZIN |
| dapagliflozin | DAPAGLIFLOZIN | Macleods Pharmaceuticals Limited | 91373924-66dc-4277-aaf2-8536e81a0e4d | 2026-07-09 | Warnings, Adverse reactions | dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Florida Pharmaceutical Products, LLC | 20a83ea2-6ad8-4bbb-b516-73c0a9e37399 | 2026-07-02 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | ANI Pharmaceuticals, Inc. | 6425d240-5dd9-4a2c-9348-f8a859702850 | 2026-06-29 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Ascend Laboratories, LLC | b6b8a10c-64c3-4856-8961-d72d68784f5d | 2026-06-25 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Alembic Pharmaceuticals Inc. | 840e2146-2383-489b-bcc4-fecfe986685a | 2026-06-23 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Zydus Pharmaceuticals USA Inc. | 17586ec6-0104-4b08-ad87-12a837568d6c | 2026-06-22 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Novadoz Pharmaceuticals LLC | 107b4d25-4764-42b7-80e3-9aaff20865ed | 2026-06-17 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| FARXIGA | DAPAGLIFLOZIN | AstraZeneca Pharmaceuticals LP | 72ad22ae-efe6-4cd6-a302-98aaee423d69 | 2026-06-03 | Warnings, Adverse reactions | DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Prasco Laboratories | 3aba33aa-f8c6-4b10-85c8-dfa14578d07c | 2026-06-03 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | AvKARE | 52a778e7-6044-2049-e063-6294a90aa0b7 | 2026-05-27 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | A-S Medication Solutions | addc6ead-f9e3-4b40-aed1-bc008a5c9b0f | 2026-05-18 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | A-S Medication Solutions | c4264ff6-5199-49e9-91d3-3ad67b42f88d | 2026-05-18 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| FARXIGA | DAPAGLIFLOZIN | REMEDYREPACK INC. | ef9e9c8c-5460-4193-952a-0c249dd071bd | 2026-04-24 | Warnings, Adverse reactions | DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Alembic Pharmaceuticals Limited | d44f7eed-dd51-40d1-8408-8fb331e1f1f6 | 2026-04-21 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Apotex Corp. | bd9766c5-104f-4636-897d-b6c92eb94f18 | 2026-04-10 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Cipla USA Inc. | a2f86c0a-ce78-4d06-b5d8-ed457c8e3614 | 2026-04-08 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Zydus Lifesciences Limited | db668c5c-2d49-41c8-8ffd-c2b2652b621a | 2026-04-06 | Dapagliflozin DAPAGLIFLOZIN | |
| Dapagliflozin | DAPAGLIFLOZIN | Lupin Pharmaceuticals, Inc. | 08baca21-e39e-4e61-961f-d89432fe8007 | 2026-04-02 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 63097 | ORIG | 2020-05-19 |